The New England Journal of Medicine, ISSN 0028-4793, 05/2012, Volume 366, Issue 18, pp. 1663 - 1673
This trial compared two thyrotropin-stimulation methods and two 131I doses for postoperative ablation in patients with low-risk thyroid cancer. Rates of...
RECOMBINANT HUMAN THYROTROPIN | CARCINOMA PATIENTS | MEDICINE, GENERAL & INTERNAL | STIMULATED THYROGLOBULIN | REMNANT ABLATION | HORMONE WITHDRAWAL | FOLLOW-UP | PREDICTIVE-VALUE | SERUM THYROGLOBULIN LEVELS | QUALITY-OF-LIFE | RADIOACTIVE IODINE | Adenocarcinoma, Follicular - radiotherapy | Follow-Up Studies | Neck - diagnostic imaging | Humans | Middle Aged | Ablation Techniques | Male | Iodine Radioisotopes - adverse effects | Iodine Radioisotopes - therapeutic use | Thyrotropin - adverse effects | Thyroid Hormones - blood | Adenocarcinoma, Follicular - drug therapy | Ultrasonography | Adult | Female | Thyrotropin - therapeutic use | Thyroid Hormones - therapeutic use | Adenocarcinoma, Follicular - surgery | Thyroid Neoplasms - surgery | Carcinoma, Papillary - drug therapy | Treatment Outcome | Combined Modality Therapy | Thyroid Neoplasms - radiotherapy | Carcinoma, Papillary - surgery | Thyroidectomy | Hypothyroidism - etiology | Carcinoma, Papillary - radiotherapy | Thyroid Neoplasms - drug therapy | Quality of Life | Drugs | Dose-response relationship (Biochemistry) | Treatment outcome | Evaluation | Usage | Care and treatment | Patient outcomes | Radiofrequency ablation | Product/Service Evaluations | Thyroid cancer | Thyrotropin | Dosage and administration | Drug therapy, Combination | Drug therapy | Isotopes | Iodine | Risk groups | Event-related potentials | Thyroid gland | Contamination | Thyroid carcinoma | Metastases | Thyroid-stimulating hormone | Thyroglobulin | Neck | Cancer | Thyroid
RECOMBINANT HUMAN THYROTROPIN | CARCINOMA PATIENTS | MEDICINE, GENERAL & INTERNAL | STIMULATED THYROGLOBULIN | REMNANT ABLATION | HORMONE WITHDRAWAL | FOLLOW-UP | PREDICTIVE-VALUE | SERUM THYROGLOBULIN LEVELS | QUALITY-OF-LIFE | RADIOACTIVE IODINE | Adenocarcinoma, Follicular - radiotherapy | Follow-Up Studies | Neck - diagnostic imaging | Humans | Middle Aged | Ablation Techniques | Male | Iodine Radioisotopes - adverse effects | Iodine Radioisotopes - therapeutic use | Thyrotropin - adverse effects | Thyroid Hormones - blood | Adenocarcinoma, Follicular - drug therapy | Ultrasonography | Adult | Female | Thyrotropin - therapeutic use | Thyroid Hormones - therapeutic use | Adenocarcinoma, Follicular - surgery | Thyroid Neoplasms - surgery | Carcinoma, Papillary - drug therapy | Treatment Outcome | Combined Modality Therapy | Thyroid Neoplasms - radiotherapy | Carcinoma, Papillary - surgery | Thyroidectomy | Hypothyroidism - etiology | Carcinoma, Papillary - radiotherapy | Thyroid Neoplasms - drug therapy | Quality of Life | Drugs | Dose-response relationship (Biochemistry) | Treatment outcome | Evaluation | Usage | Care and treatment | Patient outcomes | Radiofrequency ablation | Product/Service Evaluations | Thyroid cancer | Thyrotropin | Dosage and administration | Drug therapy, Combination | Drug therapy | Isotopes | Iodine | Risk groups | Event-related potentials | Thyroid gland | Contamination | Thyroid carcinoma | Metastases | Thyroid-stimulating hormone | Thyroglobulin | Neck | Cancer | Thyroid
Journal Article
The Journal of Nuclear Medicine, ISSN 0161-5505, 01/2018, Volume 59, Issue 1, p. 121
Perturbation of thyroid iodide uptake is a well-documented side effect of the use of iodinated contrast media (ICM) administered intravenously. This side...
Nuclear medicine | Intravenous administration | Glands | Thyroid gland | Thyroid carcinoma | NIS protein | Reduction | Animal tissues | Potassium iodides | Contrast media | Iodine | Thyroid | Formulations | Medical imaging | Iodides | Salivary glands | Iodine 131 | Oral administration | Organs | Mass spectroscopy | Patients | Radioprotection | Single photon emission computed tomography | Contamination | Contrast agents | Side effects | Cell lines | Thyrocytes | Potassium iodide | Mass spectrometry | Potassium
Nuclear medicine | Intravenous administration | Glands | Thyroid gland | Thyroid carcinoma | NIS protein | Reduction | Animal tissues | Potassium iodides | Contrast media | Iodine | Thyroid | Formulations | Medical imaging | Iodides | Salivary glands | Iodine 131 | Oral administration | Organs | Mass spectroscopy | Patients | Radioprotection | Single photon emission computed tomography | Contamination | Contrast agents | Side effects | Cell lines | Thyrocytes | Potassium iodide | Mass spectrometry | Potassium
Journal Article
The Lancet Diabetes & Endocrinology, ISSN 2213-8587, 08/2018, Volume 6, Issue 8, pp. 618 - 626
In ESTIMABL1, a randomised phase 3 trial of radioactive iodine ( I) administration after complete surgical resection in patients with low-risk thyroid cancer,...
I-131 | PERSISTENT | STIMULATED THYROGLOBULIN | SERUM THYROGLOBULIN MEASUREMENT | ENDOCRINOLOGY & METABOLISM | SURVEILLANCE | HORMONE WITHDRAWAL | RECURRENCE | NECK | RADIOIODINE ABLATION | CARCINOMA | Ablation (Surgery) | Usage | Care and treatment | Thyroid cancer | Research | Patient outcomes | Life Sciences | Cancer
I-131 | PERSISTENT | STIMULATED THYROGLOBULIN | SERUM THYROGLOBULIN MEASUREMENT | ENDOCRINOLOGY & METABOLISM | SURVEILLANCE | HORMONE WITHDRAWAL | RECURRENCE | NECK | RADIOIODINE ABLATION | CARCINOMA | Ablation (Surgery) | Usage | Care and treatment | Thyroid cancer | Research | Patient outcomes | Life Sciences | Cancer
Journal Article
Journal of Nuclear Medicine, ISSN 0161-5505, 01/2018, Volume 59, Issue 1, pp. 121 - 126
Perturbation of thyroid iodide uptake is a well-documented side effect of the use of iodinated contrast media (ICM) administered intravenously. This side...
Free iodide | Salivary glands | Iodide uptake | Iodinated contrast media | Thyroid | iodinated contrast media | URINARY IODINE | INDUCED APOPTOSIS | salivary glands | free iodide | iodide uptake | CANCER | NA+/I-SYMPORTER DISTRIBUTION | COMPUTED-TOMOGRAPHY | thyroid | RADIOIODINE THERAPY | IN-VIVO | MEDIA | TISSUES | DYSFUNCTION | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
Free iodide | Salivary glands | Iodide uptake | Iodinated contrast media | Thyroid | iodinated contrast media | URINARY IODINE | INDUCED APOPTOSIS | salivary glands | free iodide | iodide uptake | CANCER | NA+/I-SYMPORTER DISTRIBUTION | COMPUTED-TOMOGRAPHY | thyroid | RADIOIODINE THERAPY | IN-VIVO | MEDIA | TISSUES | DYSFUNCTION | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
Journal Article
Thyroid, ISSN 1050-7256, 11/2016, Volume 26, Issue 11, pp. 1614 - 1622
Background: MicroSPECT/CT imaging was used to quantitatively evaluate how iodide uptake in the mouse thyroid is influenced by (i) route of iodine...
Thyroid Radiology and Nuclear Medicine | Differentiated thyroid carcinoma | Hormone replacement therapy | Recombinant human TSH | MicroSPECT/CT | Iodine administration route | Radioiodine therapy | iodine administration route | differentiated thyroid carcinoma | microSPECT/CT | CANCER | radioiodine therapy | THERAPY | NA/I SYMPORTER | RHTSH | SODIUM-IODIDE SYMPORTER | ENDOCRINOLOGY & METABOLISM | recombinant human TSH | hormone replacement therapy | GENE-TRANSFER | SODIUM/IODIDE-SYMPORTER | CARCINOMA | EXPRESSION | VECTORS | Injections, Intravenous | Diet - adverse effects | Humans | Tomography, Emission-Computed, Single-Photon | Hormone Replacement Therapy - adverse effects | Recombinant Proteins - adverse effects | Thyrotropin - administration & dosage | Tissue Distribution | Radiopharmaceuticals - metabolism | Thyrotropin - adverse effects | Triiodothyronine - metabolism | Iodine - administration & dosage | Sodium Pertechnetate Tc 99m - pharmacokinetics | Thyrotropin - pharmacology | Injections, Subcutaneous | Sodium Pertechnetate Tc 99m - metabolism | Female | Triiodothyronine - pharmacokinetics | Thyroid Gland - drug effects | Triiodothyronine - administration & dosage | Radiopharmaceuticals - pharmacokinetics | Administration, Oral | Mice, Inbred C57BL | Injections, Intraperitoneal | Recombinant Proteins - pharmacology | Iodine Radioisotopes - pharmacokinetics | Recombinant Proteins - administration & dosage | Thyroid Gland - diagnostic imaging | Radiopharmaceuticals - administration & dosage | Iodine Radioisotopes - administration & dosage | Animals | Iodine - adverse effects | Iodine Radioisotopes - metabolism | Thyroid Gland - metabolism
Thyroid Radiology and Nuclear Medicine | Differentiated thyroid carcinoma | Hormone replacement therapy | Recombinant human TSH | MicroSPECT/CT | Iodine administration route | Radioiodine therapy | iodine administration route | differentiated thyroid carcinoma | microSPECT/CT | CANCER | radioiodine therapy | THERAPY | NA/I SYMPORTER | RHTSH | SODIUM-IODIDE SYMPORTER | ENDOCRINOLOGY & METABOLISM | recombinant human TSH | hormone replacement therapy | GENE-TRANSFER | SODIUM/IODIDE-SYMPORTER | CARCINOMA | EXPRESSION | VECTORS | Injections, Intravenous | Diet - adverse effects | Humans | Tomography, Emission-Computed, Single-Photon | Hormone Replacement Therapy - adverse effects | Recombinant Proteins - adverse effects | Thyrotropin - administration & dosage | Tissue Distribution | Radiopharmaceuticals - metabolism | Thyrotropin - adverse effects | Triiodothyronine - metabolism | Iodine - administration & dosage | Sodium Pertechnetate Tc 99m - pharmacokinetics | Thyrotropin - pharmacology | Injections, Subcutaneous | Sodium Pertechnetate Tc 99m - metabolism | Female | Triiodothyronine - pharmacokinetics | Thyroid Gland - drug effects | Triiodothyronine - administration & dosage | Radiopharmaceuticals - pharmacokinetics | Administration, Oral | Mice, Inbred C57BL | Injections, Intraperitoneal | Recombinant Proteins - pharmacology | Iodine Radioisotopes - pharmacokinetics | Recombinant Proteins - administration & dosage | Thyroid Gland - diagnostic imaging | Radiopharmaceuticals - administration & dosage | Iodine Radioisotopes - administration & dosage | Animals | Iodine - adverse effects | Iodine Radioisotopes - metabolism | Thyroid Gland - metabolism
Journal Article
The Journal of Nuclear Medicine, ISSN 0161-5505, 05/2017, Volume 58, p. 75
Objectives: During the follow-up of patients treated for malignant brain tumors (BT), the differential diagnosis between recurrence (REC) and radiation...
Immunohistochemistry | Brain | Nuclear medicine | Nuclear magnetic resonance--NMR | Brain tumors | Radiation | Oncology | Medical diagnosis | Necrosis | Metastases | Spectrometry | Surgery | Neostriatum | Tomography | Differential diagnosis | Diagnosis | Medical imaging | Decision making | Positron emission | Fluorine isotopes | Radiation therapy | Management | Patients | Chemotherapy | Magnetic resonance imaging | Perfusion | Positron emission tomography | Tumors
Immunohistochemistry | Brain | Nuclear medicine | Nuclear magnetic resonance--NMR | Brain tumors | Radiation | Oncology | Medical diagnosis | Necrosis | Metastases | Spectrometry | Surgery | Neostriatum | Tomography | Differential diagnosis | Diagnosis | Medical imaging | Decision making | Positron emission | Fluorine isotopes | Radiation therapy | Management | Patients | Chemotherapy | Magnetic resonance imaging | Perfusion | Positron emission tomography | Tumors
Journal Article
Thyroid, ISSN 1050-7256, 09/2018, Volume 28, Issue 9, pp. 1174 - 1179
Background: Dysregulation of the phosphatidylinositol 3-kinase (PI3K) pathway is frequent in advanced follicular (FTC) and poorly differentiated thyroid (PDTC)...
Thyroid Cancer and Nodules | targeted therapy | poorly differentiated thyroid carcinoma | PI3 kinase pathway | follicular thyroid carcinoma | refractory thyroid cancer | SOLID TUMORS | SORAFENIB | CELL CARCINOMA | BKM120 | TARGETED THERAPIES | ENDOCRINOLOGY & METABOLISM | PHASE-3 TRIAL | DOUBLE-BLIND | MOLECULAR PATHOGENESIS | PAPILLARY | GENETIC ALTERATIONS | Thyroid Cancer, Papillary - drug therapy | Adenocarcinoma, Follicular - pathology | Phosphatidylinositol 3-Kinase - antagonists & inhibitors | Humans | Middle Aged | Male | Treatment Outcome | Antineoplastic Agents - therapeutic use | Enzyme Inhibitors - therapeutic use | Disease Progression | Pilot Projects | Aminopyridines - therapeutic use | Thyroid Neoplasms - drug therapy | Progression-Free Survival | Thyroid Cancer, Papillary - pathology | Adenocarcinoma, Follicular - drug therapy | Aged, 80 and over | Adult | Female | Aged | Morpholines - therapeutic use | Thyroid Neoplasms - pathology | Index Medicus
Thyroid Cancer and Nodules | targeted therapy | poorly differentiated thyroid carcinoma | PI3 kinase pathway | follicular thyroid carcinoma | refractory thyroid cancer | SOLID TUMORS | SORAFENIB | CELL CARCINOMA | BKM120 | TARGETED THERAPIES | ENDOCRINOLOGY & METABOLISM | PHASE-3 TRIAL | DOUBLE-BLIND | MOLECULAR PATHOGENESIS | PAPILLARY | GENETIC ALTERATIONS | Thyroid Cancer, Papillary - drug therapy | Adenocarcinoma, Follicular - pathology | Phosphatidylinositol 3-Kinase - antagonists & inhibitors | Humans | Middle Aged | Male | Treatment Outcome | Antineoplastic Agents - therapeutic use | Enzyme Inhibitors - therapeutic use | Disease Progression | Pilot Projects | Aminopyridines - therapeutic use | Thyroid Neoplasms - drug therapy | Progression-Free Survival | Thyroid Cancer, Papillary - pathology | Adenocarcinoma, Follicular - drug therapy | Aged, 80 and over | Adult | Female | Aged | Morpholines - therapeutic use | Thyroid Neoplasms - pathology | Index Medicus
Journal Article
Bulletin du Cancer, ISSN 0007-4551, 09/2016, Volume 103, Issue 9, pp. 735 - 742
Background FDG PET (PET) ± computed tomography (CT) has increasingly been used in some areas of oncology imaging. It is sometimes performed outside...
Soft tissue sarcoma | Adult | Bone sarcoma | PET-CT | PET
Soft tissue sarcoma | Adult | Bone sarcoma | PET-CT | PET
Journal Article
Thyroid, ISSN 1050-7256, 09/2010, Volume 20, Issue 9, pp. 1037 - 1040
Background: Struma ovarii (SO) is extremely rare, with less than 200 reported cases in the medical literature. SO is defined by the presence of an ovarian...
OF-THE-LITERATURE | ENDOCRINOLOGY & METABOLISM | Ovarian Neoplasms - diagnosis | Humans | Middle Aged | Pelvic Neoplasms - diagnostic imaging | Liver Neoplasms - diagnostic imaging | Thyroidectomy | Pelvic Neoplasms - secondary | Radiography | Thyroglobulin - blood | Iodine Radioisotopes - therapeutic use | Fatal Outcome | Peritoneal Neoplasms - diagnostic imaging | Female | Liver Neoplasms - secondary | Cachexia - metabolism | Carcinoid Tumor - diagnosis | Second-Look Surgery | Struma Ovarii - diagnosis | Peritoneal Neoplasms - secondary | Case studies | Complications and side effects | Care and treatment | Thyroid cancer | Ovariectomy | Patient outcomes | Development and progression | Health aspects | Risk factors | Ovarian cancer
OF-THE-LITERATURE | ENDOCRINOLOGY & METABOLISM | Ovarian Neoplasms - diagnosis | Humans | Middle Aged | Pelvic Neoplasms - diagnostic imaging | Liver Neoplasms - diagnostic imaging | Thyroidectomy | Pelvic Neoplasms - secondary | Radiography | Thyroglobulin - blood | Iodine Radioisotopes - therapeutic use | Fatal Outcome | Peritoneal Neoplasms - diagnostic imaging | Female | Liver Neoplasms - secondary | Cachexia - metabolism | Carcinoid Tumor - diagnosis | Second-Look Surgery | Struma Ovarii - diagnosis | Peritoneal Neoplasms - secondary | Case studies | Complications and side effects | Care and treatment | Thyroid cancer | Ovariectomy | Patient outcomes | Development and progression | Health aspects | Risk factors | Ovarian cancer
Journal Article
European Journal of Endocrinology, ISSN 0804-4643, 04/2016, Volume 174, Issue 4, pp. 491 - 502
Objective: While radioiodine therapy is commonly used for treating Graves' disease, a prolonged and clinical hypothyroidism may result in disabling symptoms...
BENIGN THYROID-DISEASES | SURGERY | AGENCY | REPORTED OUTCOMES | RECOMMENDATIONS | OPHTHALMOPATHY | ENDOCRINOLOGY & METABOLISM | THYROXINE | I-131 THERAPY | QUESTIONNAIRE | CANCER-MORTALITY | Early Medical Intervention - methods | Hyperthyroidism - radiotherapy | Drug Administration Schedule | Follow-Up Studies | Humans | Middle Aged | Thyroxine - administration & dosage | Graves Disease - drug therapy | Hyperthyroidism - drug therapy | Male | Treatment Outcome | Chemoprevention - adverse effects | Graves Disease - radiotherapy | Thyroxine - adverse effects | Iodine Radioisotopes - therapeutic use | Quality of Life | Adult | Female | Chemoprevention - methods
BENIGN THYROID-DISEASES | SURGERY | AGENCY | REPORTED OUTCOMES | RECOMMENDATIONS | OPHTHALMOPATHY | ENDOCRINOLOGY & METABOLISM | THYROXINE | I-131 THERAPY | QUESTIONNAIRE | CANCER-MORTALITY | Early Medical Intervention - methods | Hyperthyroidism - radiotherapy | Drug Administration Schedule | Follow-Up Studies | Humans | Middle Aged | Thyroxine - administration & dosage | Graves Disease - drug therapy | Hyperthyroidism - drug therapy | Male | Treatment Outcome | Chemoprevention - adverse effects | Graves Disease - radiotherapy | Thyroxine - adverse effects | Iodine Radioisotopes - therapeutic use | Quality of Life | Adult | Female | Chemoprevention - methods
Journal Article
Bulletin du cancer, 09/2016, Volume 103, Issue 9, p. 735
FDG PET (PET)±computed tomography (CT) has increasingly been used in some areas of oncology imaging. It is sometimes performed outside recommendations, at...
Sarcoma - classification | Sarcoma - secondary | Humans | Middle Aged | Male | Sarcoma - therapy | Positron Emission Tomography Computed Tomography | Lung Neoplasms - secondary | Neoplasm Recurrence, Local - diagnostic imaging | Sensitivity and Specificity | Adult | Female | Fluorodeoxyglucose F18 | Lung Neoplasms - diagnostic imaging | Sarcoma - diagnostic imaging | Radiopharmaceuticals
Sarcoma - classification | Sarcoma - secondary | Humans | Middle Aged | Male | Sarcoma - therapy | Positron Emission Tomography Computed Tomography | Lung Neoplasms - secondary | Neoplasm Recurrence, Local - diagnostic imaging | Sensitivity and Specificity | Adult | Female | Fluorodeoxyglucose F18 | Lung Neoplasms - diagnostic imaging | Sarcoma - diagnostic imaging | Radiopharmaceuticals
Journal Article
European Archives of Oto-Rhino-Laryngology, ISSN 0937-4477, 8/2011, Volume 268, Issue 8, pp. 1205 - 1212
The impact of cervical lymph node metastases and the optimal surgical management of the neck in patients with papillary thyroid carcinoma (PTC) remain...
Medicine & Public Health | Lymph node metastases | Head and Neck Surgery | Central neck dissection | Otorhinolaryngology | Neurosurgery | Papillary thyroid carcinoma | CENTRAL COMPARTMENT DISSECTION | MANAGEMENT | PROGNOSTIC-FACTORS | OTORHINOLARYNGOLOGY | CANCER | Thyroid Neoplasms - diagnosis | Carcinoma | Lymph Nodes - pathology | Prognosis | Follow-Up Studies | Lymph Nodes - surgery | Humans | Middle Aged | Male | Incidence | Young Adult | Aged, 80 and over | Adult | Female | Retrospective Studies | Thyroid Neoplasms - surgery | France - epidemiology | Risk Factors | Lymphatic Metastasis | Neck Dissection - methods | Thyroidectomy | Thyroid Cancer, Papillary | Carcinoma, Papillary | Adolescent | Thyroid Neoplasms - secondary | Aged | Neoplasm Recurrence, Local - epidemiology | Neoplasm Staging | Care and treatment | Parathyroid hormone | Surgery | Thyroid diseases | Metastasis | Risk factors | Cancer
Medicine & Public Health | Lymph node metastases | Head and Neck Surgery | Central neck dissection | Otorhinolaryngology | Neurosurgery | Papillary thyroid carcinoma | CENTRAL COMPARTMENT DISSECTION | MANAGEMENT | PROGNOSTIC-FACTORS | OTORHINOLARYNGOLOGY | CANCER | Thyroid Neoplasms - diagnosis | Carcinoma | Lymph Nodes - pathology | Prognosis | Follow-Up Studies | Lymph Nodes - surgery | Humans | Middle Aged | Male | Incidence | Young Adult | Aged, 80 and over | Adult | Female | Retrospective Studies | Thyroid Neoplasms - surgery | France - epidemiology | Risk Factors | Lymphatic Metastasis | Neck Dissection - methods | Thyroidectomy | Thyroid Cancer, Papillary | Carcinoma, Papillary | Adolescent | Thyroid Neoplasms - secondary | Aged | Neoplasm Recurrence, Local - epidemiology | Neoplasm Staging | Care and treatment | Parathyroid hormone | Surgery | Thyroid diseases | Metastasis | Risk factors | Cancer
Journal Article
Biochemical Pharmacology, ISSN 0006-2952, 2005, Volume 70, Issue 8, pp. 1167 - 1175
Endothelial progenitor cell (EPC) transplantation is a potential means of inducing neovascularization in vivo. However, the number of circulating EPC is...
Angiogenesis | FGF-2 | Fucoidan | Alpha #6 | Endothelial progenitor cells | RECRUITMENT | alpha #6 | angiogenesis | INTEGRIN | BONE-MARROW-CELLS | SELECTIN | fucoidan | CARDIAC REGENERATION | TRANSPLANTATION | BLOCKS | endothelial progenitor cells | ANGIOGENESIS IN-VITRO | ACUTE MYOCARDIAL-INFARCTION | PHARMACOLOGY & PHARMACY | TOPCARE-AMI | Cell Proliferation | Molecular Weight | Cell Separation | Humans | Cells, Cultured | Stem Cells - cytology | Polysaccharides - pharmacology | Endothelium - cytology | Endothelium - drug effects | Phenotype | Flow Cytometry | Fibroblast Growth Factor 2 - metabolism | Polysaccharides - chemistry | Stem Cells - drug effects | Laminin - metabolism | Neovascularization, Physiologic | Phosphates | Laminin | Von Willebrand factor | Genetic aspects | Fibroblast growth factors | Neovascularization | Vascular endothelial growth factor | Integrins | Endothelium
Angiogenesis | FGF-2 | Fucoidan | Alpha #6 | Endothelial progenitor cells | RECRUITMENT | alpha #6 | angiogenesis | INTEGRIN | BONE-MARROW-CELLS | SELECTIN | fucoidan | CARDIAC REGENERATION | TRANSPLANTATION | BLOCKS | endothelial progenitor cells | ANGIOGENESIS IN-VITRO | ACUTE MYOCARDIAL-INFARCTION | PHARMACOLOGY & PHARMACY | TOPCARE-AMI | Cell Proliferation | Molecular Weight | Cell Separation | Humans | Cells, Cultured | Stem Cells - cytology | Polysaccharides - pharmacology | Endothelium - cytology | Endothelium - drug effects | Phenotype | Flow Cytometry | Fibroblast Growth Factor 2 - metabolism | Polysaccharides - chemistry | Stem Cells - drug effects | Laminin - metabolism | Neovascularization, Physiologic | Phosphates | Laminin | Von Willebrand factor | Genetic aspects | Fibroblast growth factors | Neovascularization | Vascular endothelial growth factor | Integrins | Endothelium
Journal Article
World Journal of Surgical Oncology, ISSN 1477-7819, 04/2009, Volume 7, Issue 1, pp. 40 - 40
Background and aims: To show the benefits of Ultrasonography in the diagnosis of great vein involvement in the neck and mediastinum in thyroid malignancies...
SURGERY | DOPPLER US | VEINS | ONCOLOGY | NECK | CARCINOMA | CANCER | FLOW | Ultrasonography, Doppler | Humans | Middle Aged | Thyroid Neoplasms - complications | Male | Thyroid Neoplasms - therapy | Aged, 80 and over | Adult | Female | Superior Vena Cava Syndrome - etiology | Aged | Superior Vena Cava Syndrome - diagnostic imaging | Thyroid Neoplasms - pathology | Doppler ultrasonography | Blood circulation disorders | Usage | Care and treatment | Thyroid cancer | Patient outcomes | Development and progression | Diagnosis | Health aspects | Risk factors
SURGERY | DOPPLER US | VEINS | ONCOLOGY | NECK | CARCINOMA | CANCER | FLOW | Ultrasonography, Doppler | Humans | Middle Aged | Thyroid Neoplasms - complications | Male | Thyroid Neoplasms - therapy | Aged, 80 and over | Adult | Female | Superior Vena Cava Syndrome - etiology | Aged | Superior Vena Cava Syndrome - diagnostic imaging | Thyroid Neoplasms - pathology | Doppler ultrasonography | Blood circulation disorders | Usage | Care and treatment | Thyroid cancer | Patient outcomes | Development and progression | Diagnosis | Health aspects | Risk factors
Journal Article
Thyroid, ISSN 1050-7256, 11/2010, Volume 20, Issue 11, pp. 1317 - 1318
THYROID-NODULE | ENDOCRINOLOGY & METABOLISM | Diagnosis, Differential | Zenker Diverticulum - diagnostic imaging | Humans | Thyroid Nodule - diagnosis | Thyroid Nodule - diagnostic imaging | Ultrasonography | Zenker Diverticulum - diagnosis | Carcinoma - diagnosis | Female | Male | Carcinoma - diagnostic imaging | Case studies | Care and treatment | Usage | Ultrasonics in medicine | Patient outcomes | Thyroid diseases | Diverticulum | Diagnosis | Health aspects | Risk factors
Journal Article
Journal of Neuroimaging, ISSN 1051-2284, 10/2009, Volume 19, Issue 4, pp. 378 - 380
ABSTRACT We report the case of a 35‐year‐old who was referred for brain perfusion single photon emission computed tomography (SPECT) for pharmacoresistant...
Rasmussen syndrome | focal epilepsy | brain perfusion SPECT | brain hemiatrophy | Brain hemiatrophy | Focal epilepsy | Brain perfusion SPECT | TOMOGRAPHY | DIAGNOSIS | NEUROIMAGING | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | CLINICAL NEUROLOGY | Brain - diagnostic imaging | Diagnosis, Differential | Encephalitis - diagnosis | Brain - physiopathology | Encephalitis - diagnostic imaging | Humans | Tomography, Emission-Computed, Single-Photon | Cerebrovascular Circulation | Electroencephalography | Brain - blood supply | Magnetic Resonance Imaging | Encephalitis - physiopathology | Age of Onset | Adult | Female | Perfusion Imaging | Children | Seizures (Medicine) | Diseases | Brain diseases
Rasmussen syndrome | focal epilepsy | brain perfusion SPECT | brain hemiatrophy | Brain hemiatrophy | Focal epilepsy | Brain perfusion SPECT | TOMOGRAPHY | DIAGNOSIS | NEUROIMAGING | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | CLINICAL NEUROLOGY | Brain - diagnostic imaging | Diagnosis, Differential | Encephalitis - diagnosis | Brain - physiopathology | Encephalitis - diagnostic imaging | Humans | Tomography, Emission-Computed, Single-Photon | Cerebrovascular Circulation | Electroencephalography | Brain - blood supply | Magnetic Resonance Imaging | Encephalitis - physiopathology | Age of Onset | Adult | Female | Perfusion Imaging | Children | Seizures (Medicine) | Diseases | Brain diseases
Journal Article
Bulletin du Cancer, ISSN 0007-4551, 11/2008, Volume 95, Issue 11, pp. 1083 - 1087
Journal Article
Bulletin du cancer, 11/2008, Volume 95, Issue 11, p. 1083
The purpose of the present study was to retrospectively evaluate the nature and significance of unexpected focal 18-FDG uptake localized by PET/CT within the...
Fluorodeoxyglucose F18 - pharmacokinetics | Humans | Middle Aged | Tomography, X-Ray Computed - methods | Male | Precancerous Conditions - metabolism | Intestines - metabolism | Sigmoid Neoplasms - metabolism | Colonic Neoplasms - metabolism | Sigmoid Neoplasms - diagnostic imaging | Precancerous Conditions - diagnostic imaging | Rectal Neoplasms - diagnostic imaging | Aged, 80 and over | Adult | Female | Intestinal Neoplasms - diagnostic imaging | Retrospective Studies | Radiopharmaceuticals - pharmacokinetics | Intestinal Neoplasms - metabolism | Incidental Findings | Positron-Emission Tomography - methods | Colonic Neoplasms - diagnostic imaging | Intestines - diagnostic imaging | Aged | Intestinal Polyps - diagnostic imaging | Rectal Neoplasms - metabolism | Tomography, Emission-Computed | Intestinal Polyps - metabolism
Fluorodeoxyglucose F18 - pharmacokinetics | Humans | Middle Aged | Tomography, X-Ray Computed - methods | Male | Precancerous Conditions - metabolism | Intestines - metabolism | Sigmoid Neoplasms - metabolism | Colonic Neoplasms - metabolism | Sigmoid Neoplasms - diagnostic imaging | Precancerous Conditions - diagnostic imaging | Rectal Neoplasms - diagnostic imaging | Aged, 80 and over | Adult | Female | Intestinal Neoplasms - diagnostic imaging | Retrospective Studies | Radiopharmaceuticals - pharmacokinetics | Intestinal Neoplasms - metabolism | Incidental Findings | Positron-Emission Tomography - methods | Colonic Neoplasms - diagnostic imaging | Intestines - diagnostic imaging | Aged | Intestinal Polyps - diagnostic imaging | Rectal Neoplasms - metabolism | Tomography, Emission-Computed | Intestinal Polyps - metabolism
Journal Article
No results were found for your search.
Cannot display more than 1000 results, please narrow the terms of your search.